Work

47 (PB035): MOMA-313 is a potent, selective Polθ inhibitor that enhances response to PARP inhibition in HR-deficient tumor models

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114574

Authors: E. Evans, M. Reutershan, V. Motwani, K. McGlynn, Y. Bai, C. Quinn, M. Dhingra, C. Gao, D. Waller, S. Nabhan, H. Bitter, T. Guzi, P. Hammerman, J. Krall

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403749040

FWCI:

Cites:

Cited by:

Related to: 10